Literature DB >> 6228286

Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.

C M Yates, J Simpson, A Gordon, A F Maloney, Y Allison, I M Ritchie, A Urquhart.   

Abstract

Noradrenaline, dopamine, homovanillic acid (HVA), choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) levels were measured in post-mortem brains from 8 cases of pre-senile Alzheimer-type dementia (ATD), 5 cases of senile ATD, 4 cases of Down's syndrome aged 53-57 years, one 27-year-old case of Down's syndrome and 13 controls. In the controls, the concentration of noradrenaline in hypothalamus (P less than 0.05) and mamillary body (P less than 0.02) decreased with age. Compared with age-matched controls, noradrenaline levels in these areas were more markedly reduced in pre-senile ATD (P less than 0.01), the 53-57-year-old cases of Down's syndrome (P less than 0.001) and in the 27-year-old Down's, than in senile ATD (hypothalamus P less than 0.05, mamillary body, n.s.). Dopamine and HVA concentrations in caudate nucleus were unaltered in pre-senile or senile ATD but dopamine was decreased (P less than 0.01) in the older cases, although not in the 27-year-old case, of Down's syndrome. In the olfactory tubercle in ATD the level of HVA was unaltered but the activity of ChAT was decreased (P less than 0.01). ChAT activity was reduced in pre-senile ATD (P less than 0.001), the older Down's cases (P less than 0.01) but not the young Down's case, and senile ATD (P less than 0.001) in the temporal cortex and in pre-senile ATD (P less than 0.001) and the older Down's cases (P less than 0.001) but not senile ATD in the caudate nucleus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6228286     DOI: 10.1016/0006-8993(83)91179-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  41 in total

1.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.

Authors:  M O Habert; U Spampinato; J L Mas; M L Piketty; M C Bourdel; J de Recondo; P Rondot; S Askienazy
Journal:  Eur J Nucl Med       Date:  1991

2.  Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse.

Authors:  P Corsi; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

Review 4.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

5.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities.

Authors:  H Sago; E J Carlson; D J Smith; J Kilbridge; E M Rubin; W C Mobley; C J Epstein; T T Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  The basis for behavioural disturbances in dementia.

Authors:  K A Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

7.  Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  H Godridge; G P Reynolds; C Czudek; N A Calcutt; M Benton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

8.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

Review 9.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 10.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.